目的观察通腑增液法联合二甲双胍加格列美脲治疗肺胃燥热型2型糖尿病(T2DM)并发便秘临床疗效。方法将113例T2DM患者随机分为2组。治疗组57例予通腑增液法联合二甲双胍加格列美脲治疗,对照组56例予酚酞片口服或外用开塞露联合格列美脲加...目的观察通腑增液法联合二甲双胍加格列美脲治疗肺胃燥热型2型糖尿病(T2DM)并发便秘临床疗效。方法将113例T2DM患者随机分为2组。治疗组57例予通腑增液法联合二甲双胍加格列美脲治疗,对照组56例予酚酞片口服或外用开塞露联合格列美脲加二甲双胍治疗。2组均治疗1年,观察2组治疗前后体质量指数(BMI)、血压(BP)、糖化血红蛋白(Hb Alc)、空腹血糖(FPG)、餐后2 h血糖(2 h PG)及空腹胰岛素(FINS)等指标,并计算胰岛素抵抗指数(HOMA-IR)、胰岛素敏感指数(IAI),并观察2组治疗前后便秘主症评分情况。结果 2组治疗后BP、Hb Alc、FPG、2 h PG、FINS、HOMA-IR、IAI均改善(P<0.05),且治疗组改善优于对照组(P<0.05)。2组治疗后便秘主症评分均改善(P<0.05),且治疗组改善优于对照组(P<0.05)。结论通腑增液法治疗糖尿病并发便秘能显著降低血糖,改善胰岛素抵抗,同时具有一定程度降压的作用。展开更多
The construction of the Tis Abay II hydro power project in Ethiopia, which is considered to be a key element in Ethiopia's power development programme, is nearing completion. It is hoped that the US$63M project, w...The construction of the Tis Abay II hydro power project in Ethiopia, which is considered to be a key element in Ethiopia's power development programme, is nearing completion. It is hoped that the US$63M project, which is funded by the Ethiopian government, will help the country meet its 10-12% annual growth in electricity demand and support the expanding economy.展开更多
文摘目的观察通腑增液法联合二甲双胍加格列美脲治疗肺胃燥热型2型糖尿病(T2DM)并发便秘临床疗效。方法将113例T2DM患者随机分为2组。治疗组57例予通腑增液法联合二甲双胍加格列美脲治疗,对照组56例予酚酞片口服或外用开塞露联合格列美脲加二甲双胍治疗。2组均治疗1年,观察2组治疗前后体质量指数(BMI)、血压(BP)、糖化血红蛋白(Hb Alc)、空腹血糖(FPG)、餐后2 h血糖(2 h PG)及空腹胰岛素(FINS)等指标,并计算胰岛素抵抗指数(HOMA-IR)、胰岛素敏感指数(IAI),并观察2组治疗前后便秘主症评分情况。结果 2组治疗后BP、Hb Alc、FPG、2 h PG、FINS、HOMA-IR、IAI均改善(P<0.05),且治疗组改善优于对照组(P<0.05)。2组治疗后便秘主症评分均改善(P<0.05),且治疗组改善优于对照组(P<0.05)。结论通腑增液法治疗糖尿病并发便秘能显著降低血糖,改善胰岛素抵抗,同时具有一定程度降压的作用。
文摘The construction of the Tis Abay II hydro power project in Ethiopia, which is considered to be a key element in Ethiopia's power development programme, is nearing completion. It is hoped that the US$63M project, which is funded by the Ethiopian government, will help the country meet its 10-12% annual growth in electricity demand and support the expanding economy.
